In light of recent wins for mRNA vaccine makers, UCSC RNA Center Co-Director Jeremy Sanford describes the versatility of the ...

The experimental mRNA vaccine successfully cleared phase 3 clinical trials, the last step necessary before it can be approved ...

False narratives could undermine public confidence in an important tool that may help prevent or treat cancer in the future.

The personalized cancer vaccine being developed by Moderna and Merck has boosted hopes that mRNA technology could open up a ...

How does Moderna’s new melanoma vaccine work – and could it treat other cancers? - Melanoma is the most aggressive form of ...

Moderna and Merck's personalised mRNA cancer vaccine lowers melanoma recurrence, marking a breakthrough in targeted cancer treatment research. Read more at straitstimes.com. Read more at straitstimes.

In a new study, scientists from Johns Hopkins Medicine report that an experimental mRNA-based platform has the potential to ...

Individualized vaccines are built from resected tumor, using analytics to prioritize neoantigens most likely to be immunogenic, then encoding these targets into an mRNA construct tailored to each ...

Personalized mRNA vaccines are showing promise as a new way to fight cancer, particularly melanoma. The vaccines are designed ...

In a new study, scientists from Johns Hopkins Medicine report that an experimental mRNA-based platform has the potential to ...

This flu season, some people will have a choice between getting the standard flu shot or the new mRNA flu vaccine, according ...

New mRNA vaccines have the potential to fight the flu and a form of cancer. If they pan out, they could save thousands of ...